Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning
暂无分享,去创建一个
T. Zimmerman | R. Larson | W. Stock | D. Pollyea | L. Godley | A. Artz | J. Kline | K. Besien | E. Rich | K. Thompson | K. Pursell